Company: BCS
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0000312069-25-000114
Chunk: 311

Company: BARCLAYS PLC
Filing Date: 2025-02-13
Form: 20-F
Chunk 311
---
31 August 2024. 3 Diane Schueneman stepped down from the Board with effect from 31 January 2025. 4 Brian Shea was appointed to the Board with effect from 19 July 2024. Chairman and Non-Executive Directors: Statement of implementation of remuneration policy in 2025 The fees for Non-Executive Directors and the Chairman are reviewed annually. The fees for Non-Executive Directors (including Board and Board Committee roles) were reviewed in December 2024 and increased by 2% and the fees for the Chairman were reviewed in the early part of 2025 and increased by 8% (see the Committee Chair&#8217;s annual statement from page112 for further information). Both increases in fees take effect from 1 January 2025 and are set out in the table below. 1 January 2025 1 January 2024 &pound; &pound; Chairman1 925,000 856,800 Board member 98,300 96,400 Additional responsibilities Senior Independent Director 39,300 38,600 Chair of Board Audit or Risk Committee 87,400 85,700 Chair of Board Remuneration Committee 76,500 75,000 Membership of Board Audit, Remuneration or Risk Committee 32,700 32,100 Membership of Board Nominations Committee 16,400 16,100 Membership of Board Sustainability Committee 15,600 15,300 Note: 1 The Chairman does not receive any fees in addition to the Chairman fees shown above. Strategy Shareholder information Climate and sustainability report Risk review Financial review Financial statements Barclays PLC 2024 Annual Report on Form 20-F 161Governance Remuneration report (continued)

Directors&#8217; shareholdings and share interests Interests in Barclays PLC shares The table below shows the number of ordinary shares of 25p each of the Company (ordinary shares) owned beneficially by each person who served as a Director during 2024 (including any ordinary shares owned beneficially by their connected persons). The ordinary shares held carry no additional or different voting rights to those of other holders of ordinary shares. The rights attaching to ordinary shares are set out from page 108. For the Executive Directors, the table shows the number of ordinary shares over which each holds awards that are subject to either deferral terms or to deferral terms plus performance measures, and the number of shares owned outright includes shares purchased by the Director as well as shares received in relation